Search
Now showing items 1-10 of 13
Cytochrome P450 2D6 and MDR1 Gene Mutation in Relation to Mortality in Patients with Crimean-Congo Hemorrhagic Fever: A Preliminary Study
(ORTADOGU AD PRES & PUBL CO, 2009)
Objective: The aim of this study was to investigate the role of multidrug transporter P-glycoprotein 1 (MDR1), cytochrome P450 isozyme 2D6 (CYP2D6) and C-C chemokine receptor 5 (CCR5) genes in the mortality of patients ...
EVALUATION OF RESPIRATORY FINDINGS IN CRIMEAN-CONGO HEMORRHAGIC FEVER
(SOUTHEAST ASIAN MINISTERS EDUC ORGANIZATION, 2011)
Crimean-Congo hemorrhagic fever (CCHF) is a zoonotic disease with a high mortality rate causing viral hemorrhagic fever. We studies the respiratory system findings, demographics, clinical and laboratory findings of patients ...
Ocular Findings in Patients with Crimean-Congo Hemorrhagic Fever
(ELSEVIER SCIENCE INC, 2009)
PURPOSE: To describe ocular findings of patients with Crimean-Congo hemorrhagic fever (CCHF). DESIGN: Prospective, interventional, consecutive case series. METHODS: This study was conducted in Sivas, a city located in the ...
Serum Levels of Mannan-Binding Lectin in Patients with Crimean-Congo Hemorrhagic Fever
(MARY ANN LIEBERT, INC, 2010)
Objective: Mannan-binding lectin (MBL) is a central component of the innate immune response. Genetic variations in the MBL gene that reduce circulating levels and alter functional properties of the MBL are associated with ...
Relationship between IFNA1, IFNA5, IFNA10, and IFNA17 gene polymorphisms and Crimean-Congo hemorrhagic fever prognosis in a Turkish population range
(WILEY, 2016)
Crimean-Congo hemorrhagic fever (CCHF) is a fatal emerging acute viral infection. Not much is known regarding the pathogenic mechanisms and the reasons behind severe or mild disease courses in CCHF. IFN-alpha (IFNA) is one ...
Recommended precaution procedures protect healthcare workers from Crimean-Congo hemorrhagic fever virus
(ELSEVIER SCI LTD, 2013)
Objectives: The Crimean-Congo hemorrhagic fever (CCHF) virus can spread from person to person and may cause nosocomial outbreaks among healthcare workers (HCWs). The US Centers for Disease Control and Prevention have ...
Crimean-Congo Hemorrhagic Fever Virus in High-Risk Population, Turkey
(CENTERS DISEASE CONTROL, 2009)
In the Tokat and Sivas provinces of Turkey, the overall Crimean-Congo hemorrhagic fever virus (CCHFV) seroprevalence was 12.8% among 782 members of a high-risk population. CCHFV seroprevalence was associated with history ...
Toll-like receptor 8 and 9 polymorphisms in Crimean-Congo hemorrhagic fever
(ELSEVIER SCIENCE BV, 2010)
Crimean-Congo hemorrhagic fever (CCHF) is an acute viral hemorrhagic fever The clinical course and outcome of the CCHF infection are different in humans Toll like receptors (TLRs) are a family of pathogen recognition ...
Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: A quasi-experimental study from Turkey
(W B SAUNDERS CO LTD, 2009)
Objective: The aim of this study was to evaluate the efficacy of oral ribavirin treatment in patients with Crimean-Congo haemorrhagic fever (CCHF). Methods: In 2004, all patients diagnosed with CCHF were treated with oral ...
Sequential determination of serum viral titers, virus-specific IgG antibodies, and TNF-alpha, IL-6, IL-10, and IFN-gamma levels in patients with Crimean-Congo hemorrhagic fever
(BIOMED CENTRAL LTD, 2014)
Background: Although there have been a number of studies on the pathogenesis of Crimean-Congo hemorrhagic fever (CCHF) recently, knowledge on this topic is still insufficient. This study aims to reveal the kinetics of serum ...